• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Liver Cancer UK HomepageLiver Cancer UK

Part of the British Liver Trust

  • About us
  • Health professionals
  • Talk to a nurse 0800 652 7330
  • Twitter
  • Liver cancer information
    • Types of liver cancer
      • HCC liver cancer
        • Overview
        • What is HCC?
        • Symptoms
        • Risks and causes
        • Diagnosis
          • Tests
          • Questions for your doctor
        • Treatment
          • Stages
          • Early stage HCC (0-A)
          • Intermediate HCC (stage B)
          • Advanced HCC (stage C)
          • Very advanced (stage D)
          • If your HCC comes back (recurrence)
          • Check-ups
          • Outcomes (prognosis)
        • Living with HCC
      • Bile duct cancer
        • Overview
        • What is bile duct cancer?
        • Symptoms
        • Risks and causes
        • Diagnosis
          • Tests
          • Questions for your doctor
        • Treatment
          • Stages
          • If cancer can be removed
          • If cancer can’t be removed
          • If cancer is advanced or has come back
          • Questions for your doctor
          • Check-ups
          • Outcomes (prognosis)
        • Living with bile duct cancer
      • Rare types of liver cancers
      • Secondary liver cancer
    • Just diagnosed?
    • Types of treatment
      • Surgery
        • Types of surgery
        • Preparing for surgery
        • After surgery
      • Targeted cancer medicines (biological therapies)
      • Chemotherapy
      • Embolization, TACE and TARE or SIRT
      • Ablation
      • Radiotherapy
      • Treatment for symptoms and advanced cancer
      • About clinical trials
    • Risk and causes of liver cancer
    • Liver cancer tests
    • Living with liver cancer
      • Diet and exercise
      • Coping with advanced cancer
      • Mental wellbeing
      • Money matters
      • Support from others
      • Complementary and alternative therapies
      • Patient stories
    • Our booklets and resources
    • Glossary / useful words
  • Support for you
  • How you can help
  • News and blogs
  • Donate
Home » News and Blogs » New advice from NHS Scotland means SIRT is…
News

New advice from NHS Scotland means SIRT is now available for patients with hepatocellular carcinoma (HCC) in Scotland

February 10, 2023

Patients with hepatocellular carcinoma (HCC) in Scotland may now be able to access Selective Internal Radiation Therapy (SIRT) on the NHS.

SIRT was approved by NICE (National Institute for Health and Care Excellence) for use in the NHS in England and Wales in 2021. The Scottish Health Technologies Group (SHTG) has now allowed the use of SIR-Spheres® and TheraSphere™ SIRT treatments in Scotland following a request from the Scottish HepatoPancreatoBiliary Network. You can read their advice here.

SIRT is used to treat primary liver tumours that cannot be removed by surgery. It involves injecting small radioactive beads into a patient’s blood supply to the liver, so providing targeted treatment to the tumour. It can be a treatment option for selected patients for whom conventional trans-arterial therapies are inappropriate.

HCC is the most common type of primary liver cancer that originates in the liver, not due to tumours spreading from other parts of the body, and it can be challenging to treat. The incidence rate of in Scotland is close to eight people per 100,000 people and the primary cause is alcohol misuse or hepatitis C. Treatment depends on the stage of the disease and liver function and other options include surgery, ablation, trans-arterial therapies and best supportive care.

Vanessa Hebditch, Director of Communications & Policy, British Liver Trust said: “SHTG’s approval of SIRT is an important step forward in the treatment of HCC patients in Scotland. HCC is the most common form of primary liver cancer and has a poor prognosis and very few available treatments. Often, the disease is diagnosed so late that palliative care is the only option. The addition of SIRT to the available treatments not only positively impacts those individuals who for whom it is suitable but can also have a huge positive impact on their families and the wider community.”

More news items
« Liver cancer deaths are surging due to late diagnosis of the less survivable cancers
NHS on-the-spot liver scans identify hundreds at risk of cancer »

Footer

Liver Cancer UK logo
British Liver Trust logo

Quick links


  • Just been diagnosed
  • Living with cancer
  • Hepatocellular carcinoma (HCC)
  • Bile duct cancer

Contact us


Talk to a nurse on our helpline

0800 652 7330

General enquiries:

info@britishlivertrust.org.uk

01425 481 320

© British Liver Trust. All rights reserved. Registered Office: Venta Court, 20 Jewry Street, Winchester, SO23 8FE.
Registered Charity England and Wales 298858, Scotland SC042140. Company Limited by Guarantee Registered in England and Wales, Company No 2227706

Privacy policy | Cookies

Talk to a nurse on our helpline

0800 652 7330

Scroll Up